Concepedia
Statistics
Publications
11
Citations
530
H-Index
Active since
2011
Affiliations
National Cancer Centre Singapore(Current)
Novartis (Switzerland)
Singapore General Hospital
Novartis (United States)
Bioinformatics Institute
Richard Ong is an author at National Cancer Centre Singapore specializing in medicine, oncology, and molecular oncology.
Publications per year
2011–2020
FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors
Fang Li, Hung Huynh, Xiaoyan Li et al. · Cancer Discovery · 2015 · 107 citations · Full text
Medicine, Oncology, Pharmacology +16
Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus
Hung Huynh, Huai-Xiang Hao, Stephen L. Chan et al. · Molecular Cancer Therapeutics · 2015 · 80 citations
Medicine, Cancer Biology, Oncology +17
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
Hung Huynh, Liek Yeow Lee, Kah Yong Goh et al. · Hepatology · 2018 · 63 citations · Full text
Medicine, Oncology, Pharmacology +17
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma
Hung Huynh, Pierce K. H. Chow, Wai Ming Tai et al. · Journal of Hepatology · 2011 · 58 citations
Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma
Hung Huynh, Richard Ong, Khee Chee Soo · Angiogenesis · 2011 · 57 citations
1–5 of 11